The clinical landscape of lymphomas has changed dramatically over the last 2 decades, including significant progress made in the understanding and utilization of imaging modalities and the available treatment options for both indolent and aggressive lymphomas. Since the introduction of hybrid PET/CT scanners in 2001, the indications of 18F-fluorodeoxyglucose (FDG) PET/CT in the management of lymphomas have grown rapidly. In today's clinical practice, FDG PET/CT is used in successful management of the vast majority patients with lymphomas.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cpet.2023.12.014 | DOI Listing |
Publication Analysis
Top Keywords
fdg pet/ct
8
quarter-century pet/ct
4
pet/ct transformation
4
transformation oncology
4
oncology lymphoma
4
lymphoma clinical
4
clinical landscape
4
lymphomas
4
landscape lymphomas
4
lymphomas changed
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!